Siemens Healthcare (www.siemens.com/healthcare) demonstrates capabilities on its Inveon preclinical imaging system that may shorten the long path to clinical reality in drug discovery with the introduction of enhanced workflow tools at the World Molecular Imaging Congress (booth #107), in Nice, France, September 10-13. Inveon•Workplace provides customers with increased speed, quality and performance in every step of the discovery process, where time is money.
A combination of the Inveon Acquisition Workplace and Inveon Research Workplace, Inveon•Workplace offers unprecedented methods to improve overall workflow with faster PET and CT image acquisition, enriched reconstruction quality and higher performance in image visualization and analyses. The new software applications are available for all modality applications on Inveon and are currently available for all existing and new Inveon customers.
“These new tools can help speed the drug development process as they more quickly enable researchers to monitor the efficacy of compounds and measure the effects of disease progression over time,” said Michael Reitermann, chief executive officer, Molecular Imaging, Siemens Healthcare. “Because this type of research and our imaging technology are so rapidly evolving, and in many cases converging, translational research with state-of-art equipment and visualization tools is critical to successful outcomes.”
Preclinical Imaging
Other features in the Siemens booth include the Inveon modular preclinical discovery platform, which allows users to combine positron emission tomography (PET), single photon emission computed tomography (SPECT), and computed tomography (CT) acquisition systems in one unit. This scalable system also offers high-quality PET resolution and sensitivity, delivering valuable knowledge for a powerful impact. With Inveon•Workplace, Inveon now hosts a suite of research tools that integrates all modalities and seamlessly ties together every step of the research workflow. This enhanced portfolio demonstrates Siemens’ commitment to facilitating research and discovery, while driving down costs.
Also at WMIC
Case studies from early adopters of HD•PET technology will highlight the technology’s impact in clinical practice. Siemens’ HD•PET is the world’s first and only high-definition PET technology to offer consistently sharper and more clearly defined images across the entire field of view. The clarity achieved by HD•PET is the result of a unique and proprietary technology that optimizes the elements of image uniformity, resolution and contrast – that together change the whole picture. These improvements enable physicians to clearly visualize small lesions from the center to the edges of the field of view.
PETNET Solutions, a fully owned subsidiary of Siemens Medical Solutions USA, Inc., operates the largest PET radiopharmacy network with 50 radiopharmacies and distribution centers in the U.S., Korea and the United Kingdom that produce and distribute PET radiopharmaceuticals to hospitals, clinics, and research facilities for PET imaging. Recent expansion of PETNET facilities in the U.S. and a focus on international expansion serves to strengthen the current production and distribution levels of radiopharmaceuticals to hospitals that utilize PET•CT, which will help ease the burden of healthcare providers to produce their own radiopharmaceuticals. Additional growth includes the opening of PETNET’s newest radiopharmacy in Pensacola, Fla., which is the first PETNET pharmacy to be dedicated exclusively to the compounding of general nuclear medicine and SPECT radiopharmaceuticals.
Siemens also highlights the ECLIPSE™ family of cyclotrons and Explora radiochemistry synthesis products for developing and producing tracers that help characterize, quantify, and visualize the biology of disease.
The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.
